Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

A change in SALT scores of 42 or 43 indicates meaningful improvement in alopecia areata treatment.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

A woman lost all her hair after mild COVID-19, but it started to regrow after treatment with a specific medication.

Straightening and coloring hair, especially with sodium hydroxide, greatly increases protein loss.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

Dupilumab effectively reduces alopecia areata symptoms in children with atopic dermatitis.

AI can accurately measure hair loss severity in alopecia areata.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

Latanoprost 0.005% solution safely increases hair density and regrowth in scalp alopecia areata.

Tofacitinib shows promise for treating alopecia areata with significant hair regrowth and mild side effects.

Abrocitinib significantly improved hair regrowth in adolescents with alopecia areata without serious safety issues.

Triamcinolone is more effective than methotrexate for treating localized alopecia areata.

Oral tofacitinib is more effective than oral minoxidil for treating alopecia areata.

Baricitinib helps keep hair, eyebrows, and eyelashes regrown for 3 years in most people with severe hair loss.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Ritlecitinib significantly regrows scalp hair in people with alopecia areata.

Patient-reported outcomes better reflect the quality of life impact of alopecia areata than traditional severity scores.

Baricitinib effectively and safely improves hair growth in patients with severe alopecia areata.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Baricitinib helps improve hair growth in severe alopecia, with better results in less severe cases and higher doses working faster.

Stopping and restarting JAK inhibitors during pregnancy in women with alopecia areata leads to hair loss and regrowth, with most pregnancies resulting in healthy babies.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Keratin from hair binds well to gold and BMP-2, useful for bone repair.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Dupilumab may help children with alopecia areata and atopic dermatitis regrow hair.

Corin helps control salt and sweat release in sweat glands.

Combining calcipotriol with mometasone is more effective for treating alopecia areata than using mometasone alone.

Baricitinib helped regrow hair in patients with severe alopecia areata after other treatments failed.